Computer-aided design, synthesis and evaluation of new SARS-CoV-2 Mpro inhibitors based on 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold

被引:0
|
作者
Yuri A. Piven
Veronica G. Zinovich
Dmitriy N. Shcherbakov
Varvara Yu. Chirkova
Svetlana V. Belenkaya
Raman M. Puzanau
Tatyana S. Khlebnicova
Fedor A. Lakhvich
机构
[1] National Academy of Sciences of Belarus,Institute of Bioorganic Chemistry
[2] Altay State University,undefined
[3] State Research Center of Virology and Biotechnology “Vector”,undefined
[4] Health Care Institution “National Anti-Doping Laboratory”,undefined
来源
关键词
1, 5, 6, 7-Tetrahydro-4; -indazol-4-ones; SARS-CoV-2; M; 3CL; Molecular docking; Molecular dynamics;
D O I
暂无
中图分类号
学科分类号
摘要
A novel class of SARS-CoV-2 main protease (Mpro) inhibitors derived from 1,5,6,7-tetrahydro-4H-indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evaluation. After testing 29 prepared compounds for activity against Mpro, two hits with IC50 values bellow 60 μM were found with the best result of 27.31 μM for racemic amide 9m. SAR and further possibilities for hit optimization were discussed. The effectiveness of different approaches (MM/GBSA and alchemical ABFE) for protein–ligand binding affinity prediction was assessed on the basis of obtained experimental data. The best convergence was achieved when we carried out long molecular dynamics simulations (200 ns) of complexes from docking followed by calculations of free binding energies with MM/GBSA method and explicit accounting of entropy.
引用
收藏
页码:151 / 163
页数:12
相关论文
共 50 条
  • [21] Synthesis and Antimicrobial Activities of (4,5,6,7-Tetrahydro-1H-indazol-2(3H)-yl)thiazole Derivatives
    Laczkowski, Krzysztof Z.
    Misiura, Konrad
    Biernasiuk, Anna
    Malm, Anna
    LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 11 (08) : 960 - 967
  • [22] Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold
    Hassan, Abdelfattah
    Badr, Mohamed
    Abdelhamid, Dalia
    Hassan, Heba A. A.
    Abourehab, Mohammed A. S.
    Abuo-Rahma, Gamal El-Din A.
    BIOORGANIC CHEMISTRY, 2022, 120
  • [23] Design, synthesis and biological evaluation of 2-aminoquinazolin-4 (3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments
    Lee, Jun Young
    Shin, Young Sup
    Jeon, Sangeun
    Lee, Se In
    Noh, Soojin
    Cho, Jung-Eun
    Jang, Min Seong
    Kim, Seungtaek
    Song, Jong Hwan
    Kim, Hyoung Rae
    Park, Chul Min
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 39
  • [24] A facile one-pot synthesis of novel 1-substituted 2-(8-hydroxyquinolin-5-yl)-1,5,6,7-tetrahydro-6,6-dimethyl-4H-indol-4-one derivatives
    Abdel-Mohsen, Shawkat
    El-Emary, Talaat
    ARKIVOC, 2016, : 184 - 192
  • [25] Synthesis and biological evaluation of 2-benzylaminoquinazolin-4(3H)-one derivatives as a potential treatment for SARS-CoV-2
    Lee, Jun Young
    Shin, Young Sup
    Jeon, Sangeun
    Lee, Se In
    Cho, Jung-Eun
    Myung, Subeen
    Jang, Min Seong
    Kim, Seungtaek
    Song, Jong Hwan
    Kim, Hyoung Rae
    Park, Chul Min
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2022, 43 (03) : 412 - 416
  • [26] Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase.: Synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines
    Kawanaka, Y
    Kobayashi, K
    Kusuda, S
    Tatsumi, T
    Murota, M
    Nishiyama, T
    Hisaichi, K
    Fujii, A
    Hirai, K
    Nishizaki, M
    Naka, M
    Komeno, M
    Nakai, H
    Toda, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (05) : 689 - 702
  • [27] Regiospecific synthesis of 1,5,6,7-tetrahydro-4H-indo1-4-ones via dehydroxylated [3+2] cyclization of β-hydroxy ketones with cyclic enaminones
    Lan, Xin-Chan
    Chen, Ting-Ting
    Zhao, Yan
    Wu, Yu
    Wang, Jing
    Tu, Shu-Jiang
    Jiang, Bo
    Hao, Wen-Juan
    TETRAHEDRON LETTERS, 2017, 58 (15) : 1519 - 1522
  • [28] Constrained analogs of CB-1 antagonists for the treatment of obesity: Design, synthesis, and pharmacology of 1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one derivatives
    Smith, RA
    Choi, S
    Zhang, ZH
    Tomlinson, S
    Kluender, HC
    Lavoie, RC
    Fan, JM
    O'Connor, SJ
    Podlogar, BL
    Fathi, Z
    Konkar, A
    Brown, SE
    Ortiz, AA
    Natoli, J
    Kelly-Sullivan, D
    Milardo, L
    Hudgins, S
    Raphalides, C
    Evenski, J
    Jenkins, S
    Mays, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2765 - U2766
  • [29] Polymorphism in 1-(4-fluorophenyl)-3,6,6-trimethyl-2phenyl-1,5,6,7-tetrahydro-4H-indol-4-one:: A subtle interplay of weak intermolecular interactions
    Chopra, D
    Nagarajan, K
    Row, TNG
    CRYSTAL GROWTH & DESIGN, 2005, 5 (03) : 1035 - 1039
  • [30] Synthesis and anticonvulsant evaluation of some new 1,3,4,5-tetrahydro-6-alkoxy-2H-1-benzazepin-2-one derivatives
    Han, Rong-Bi
    Shao, Yun-Peng
    Wu, Hui-Fan
    Zhang, Duo
    Piao, Feng-Yu
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (06) : 2810 - 2820